The ọgwụ 'Phosphogliv'. Ojiji Guide agwọ ọrịa

N'ụwa taa, n'ebe nile ọrịa imeju. Dị ka ahụ na-eme ihe ndị bụ isi ọrụ nke detoxification ke idem, na imeju na-na-achọ a akpachara anya àgwà (a maara nke ọma ọ bụla dọkịta). Ọ bụ n'ihi nke a, e nwekwara a pụrụ iche otu nke pharmaceuticals - gepatoprotektory.

Ọgwụ "Phosphogliv" ugbu a na ọgwụ na ahụ ike omume bụ n'ebe nile. na ojiji nke a ọgwụ ndu nwere ozi ọkọlọtọ (egosi, contraindications, oghom Jeremaya mere, nakwa dị ka ihe ọmụma banyere ihe atụmatụ farmadinamiki na pharmacokinetics).

Isi ntụziaka nke ihe nke na-emepụta ọgwụ ọgwụ - imeju nchebe. N'ihi ya, pharmacological gị n'ụlọnga "Phosphogliv", ntuziaka maka ojiji nke na-akọwa n'ụzọ zuru ezu usoro nke edinam nke ọgwụ na ahụ mmadụ, a hepatoprotector.

Ke adianade ya isi nzube, ọgwụ nwere ike antiviral ọrụ, dị ka enen ke ule. Dị ka a akụrụngwa nke cell membranes, na-arụsi ọrụ ike mgwa (phosphatidylcholine) na-eme ka mweghachi na ike nke imeju cell owuwu. Nke ikpeazụ ana achi achi na mgbake nke mebiri emebi imeju (nkịtị njikọ nke enzymes na normalize mgbanwe macronutrients). Part nke sodium glycyrrhizinate ọgwụ na-eduga ná suppression nke malitere ịrịa replication na imeju mkpụrụ ndụ. Nke a bụ n'ihi na mmetuta nke interferon mmepụta, welie phagocytosis ọrụ, na ebighị nke eke na-egbu mkpụrụ ndụ.

Ọ bụ uru na-arịba ama na ihe nke ọgwụ budata ebelata ihe ize ndụ nke na-emepe emepe imeju na fibrosis nke imeju anụ ahụ.

Na mgbakwunye na n'elu nkwadebe, e nwere a pụrụ iche - na nkà mmụta ọgwụ "Phosphogliv forte." Ntuziaka maka ojiji nke ọgwụ nkwadebe bụ analogous ka ntụziaka a kọwara n'elu. A pụrụ iche mma bụ ruo ogologo oge mmetụta nke ikpeazụ.

Egosi maka ọgwụ designation:

- ịba ọcha n'anya (nnukwu ma ọ bụ ala ala ụdị);

- degenerative ọrịa imeju (steatosis, imeju, ọrịa shuga, ụkwara nta);

- imeju mmerụ ọgwụ ọjọọ na ịṅụbiga mmanya etiology;

- nnukwu na-adịghị ala ala mmebi imeju;

- iche iche igbu egbu;

- iche iche ọrịa akpụkpọ (psoriasis, eczema, atopic dermatitis, neurodermatitis).

Na ọnụnọ nke kwuru enweghị nchịkwa ọnọdụ eji na-emeso ọgwụ ọjọọ, "Phosphogliv". Ntuziaka maka ojiji na-egosi a pụrụ iche ndepụta contraindications, otu nke ndị bụ isi na-ime na lactation. Ke adianade do, ọ dị mkpa ịgakwuru ihe ókè ịkpachara anya ka nhọpụta nke gị n'ụlọnga ke ọrịa na portal ọbara mgbali.

Mmetụta ime adịkarịghị na na-tumadi na-anọchite anya dermatologic ngosipụta (ọkụ ọkụ, itching, wdg).

ọgwụ ọjọọ, "Phosphogliv" e kenyere na-anọghị nke contraindications iji na, n'ezie, ọ bụrụ na e nwere ihe ezi uche na-egosi. Ntuziaka maka ojiji nke si ọgwụ ezumike site ọgwụ naanị, nke na-echebe ọrịa si onwe ha ma na-enweghị isi iji ọgwụ enweghị a ọgwụ.

Nwere ike hepatoprotective stabilizer membranes nke imeju mkpụrụ ndụ, nakwa dị ka irè antiviral ọgwụ ọjọọ, "Phosphogliv Chiefs", ntụziaka na nke ngwa e-atụle n'ụzọ zuru ezu na n'elu, a na-eji taa ọtụtụ mgbe, ma n'ụzọ dị irè ịnagide aga-eme. N'etiti analogues nke ọgwụ nwere ike ịmata ihe dị iche 'Liv 52 "na" Essentiale ".